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Abstract
Introduction: Osteoarthritis (OA) and rheumatoid arthritis (RA) are characterised by joint inflammation and cartilage 
degradation. Although mesenchymal stem cell (MSC)-like progenitors are resident in the superficial zone of articular 
cartilage, damaged tissue does not possess the capacity for regeneration. The high levels of pro-inflammatory 
cytokines present in OA/RA joints may impede the chondrogenic differentiation of these progenitors. Interleukin (IL)-
1β activates the transcription factor nuclear factor-κB (NF-κB), which in turn activates proteins involved in matrix 
degradation, inflammation and apoptosis. Curcumin is a phytochemical capable of inhibiting IL-1β-induced activation 
of NF-κB and expression of apoptotic and pro-inflammatory genes in chondrocytes. Therefore, the aim of the present 
study was to evaluate the influence of curcumin on IL-1β-induced NF-κB signalling pathway in MSCs during 
chondrogenic differentiation.
Methods: MSCs were either cultured in a ratio of 1:1 with primary chondrocytes in high-density culture or cultured 
alone in monolayer with/without curcumin and/or IL-1β.
Results: We demonstrate that although curcumin alone does not have chondrogenic effects on MSCs, it inhibits IL-1β-
induced activation of NF-κB, activation of caspase-3 and cyclooxygenase-2 in MSCs time and concentration 
dependently, as it does in chondrocytes. In IL-1β stimulated co-cultures, four-hour pre-treatment with curcumin 
significantly enhanced the production of collagen type II, cartilage specific proteoglycans (CSPGs), β1-integrin, as well 
as activating MAPKinase signaling and suppressing caspase-3 and cyclooxygenase-2.
Conclusions: Curcumin treatment may help establish a microenvironment in which the effects of pro-inflammatory 
cytokines are antagonized, thus facilitating chondrogenesis of MSC-like progenitor cells in vivo. This strategy may 
support the regeneration of articular cartilage.
Introduction
Osteoarthritis (OA) and rheumatoid arthritis (RA)
involve degenerative changes in the joint, leading to loss
of function, pain and significant disability [1]. OA and RA
are not only common joint diseases in the elderly popula-
tion but increasingly they affect young individuals. Col-
lectively, they represent a large proportion of orthopaedic
cases [2]. Articular cartilage is an avascular, alymphatic
and aneural tissue with bradytrophic characteristics and a
very poor capacity for self-repair and regeneration [3].
Cartilage repair is ineffective and often leads to replace-
ment of the articular cartilage by a mechanically inferior
fibrocartilage tissue thus promoting progressive degener-
ation and impairment of joint function [4]. This inherent
weakness in cartilage repair highlights the acute need for
novel treatments using tissue engineering and regenera-
tive medicine, and innovative new regenerative strategies
that involve stimulation of articular cartilage repair in
vivo.
OA is characterized by an imbalance between cartilage
anabolism and catabolism. The local production and
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release of pro-inflammatory cytokines (interleukin-1β
(IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α
(TNF-α)) play a central role in the pathogenesis of OA [5-
7]. It is well known that IL-1β and TNF-α production
activates the transcription factor nuclear factor-κB (NF-
κB) in chondrocytes. Once activated, NF-κB translocates
into the nucleus, where it induces the expression of dis-
tinct subsets of genes encoding inflammatory, apoptotic
and extracellular matrix (ECM) degrading enzymes. NF-
κB activates the expression of matrix degrading enzymes
such as matrix metalloproteinases (MMPs) and enzymes
responsible for production of prostaglandins (that is,
cyclooxygenase-2 (COX-2)) leading to enhanced degra-
dation of the ECM and induction of pain [8]. Addition-
ally, in articular chondrocytes, NF-κB stimulates the
production of pro-inflammatory catabolic cytokines,
which induce apoptosis through activation of the pro-
apoptotic enzyme caspase-3 and cleavage of the DNA
repair enzyme poly(ADP-ribose)polymerase (PARP) [9].
During embryonic development, cartilage develops
from mesenchymal stem cells (MSCs) by condensation
and differentiation. Recent studies have shown that MSC-
like progenitors also exist in the superficial zone of artic-
ular cartilage and that their abundance in arthritic carti-
lage is elevated [10]. Despite this, cartilage regeneration
in vivo is inefficient and the resulting fibrocartilage is
structurally and functionally inadequate. A possible
explanation for this lack of regeneration is that the ongo-
ing inflammatory processes that occur during the course
of OA/RA result in higher synovial and circulating levels
of pro-inflammatory cytokines, which may in turn
impede the chondrogenic differentiation of cartilage resi-
dent progenitors. Therefore, blocking the pro-inflamma-
tory cytokine induced cartilage degeneration and
inflammatory cascades might create a more suitable
microenvironment for the chondrogenesis of MSC-like
progenitors.
In recent years the phytochemical curcumin has been
identified as a potent anti-inflammatory substance in sev-
eral diseases such as cancer, inflammatory bowel disease,
pancreatitis, chronic anterior uveitis and arthritis [9,11-
16]. Curcumin is a natural yellow orange dye derived
from the rhizome of Curcuma longa. It is insoluble in
water but is soluble in ethanol, dimethylsulfoxide and
other organic solvents. It has a melting point of 183°C and
a molecular weight of 368.37. Commercial curcumin con-
tains three major components: Diferuloylmethane (82%)
and its derivatives demethoxycurcumin (15%) and bisde-
methoxycurcumin (3%), together referred to as curcumi-
noids [9,11-16], all of which have anti-inflammatory
activity. Curcumin reduces tumor cell survival, tumor
expansion and secondary inflammation via NF-κB inhibi-
tion [13,17]. Further, it suppresses constitutive IκBα
phosphorylation through the inhibition of IκB kinase
[13,18]. There is increasing interest in curcumin as a ther-
apeutic option for OA and RA, with evidence that cur-
cumin inhibits the IL-1β-induced activation of NF-κB in
human articular chondrocytes [9,14]. Furthermore, in a
recent study we have demonstrated that curcumin exerts
anti-apoptotic effects on IL-1β stimulated human chon-
drocytes through inhibition of caspase-3 activation and
PARP cleavage [15].
The aim of the present investigation was to evaluate
whether IL-1β stimulated MSCs (either alone or in a co-
culture model of OA with primary chondrocytes) pre-
treated with curcumin may impede the adverse effects of
this pro-inflammatory cytokine and create a more suit-
able microenvironment for the chondrogenic differentia-
tion of cartilage resident progenitor cells.
Materials and methods
Antibodies and reagents
Polyclonal anti-collagen type II antibody (PAB746),
monoclonal anti-adult cartilage-specific proteoglycan
antibody (MAB2015), anti-β1-integrin antibody
(MAB1965), and alkaline phosphatase linked sheep anti-
mouse (AP303A) and sheep anti-rabbit secondary anti-
bodies (AP304A) for immunoblotting and immuno-elec-
tron labelling were purchased from Chemicon
International, Inc. (Temecula, CA, USA). Monoclonal
anti-β-Actin (A4700) was purchased from Sigma, St.
Louis, MO, USA). Monoclonal anti-Sox-9 was purchased
from Acris Antibodies GmbH, Hiddenhausen, Germany.
Monoclonal anti-phospho-p42/p44 ERK1/2 antibody
(610032) and polyclonal anti-Shc antibody (610082) were
purchased from BD (BD Biosciences, Erembodegem, Bel-
gium). Polyclonal anti-active caspase-3 (AF835) was pur-
chased from R&D Systems (Abingdon, UK). Antibodies
against phospho-specific IκBα (Ser 32/36) and against
anti-phospho-specific p65(NF-κB)/(Ser536) were
obtained from Cell Technology (Beverly, MA, USA). Cur-
cumin with a purity > 95% was purchased from Indsaff
(Punjab, India). This commercial source of curcumin
contains three major components: Diferuloylmethane
(the most abundant and active component of turmeric)
(82%) and its derivatives demethoxycurcumin (15%) and
bisdemethoxycurcumin (3%), together referred to as cur-
cuminoids [9,11-16]. Curcumin was dissolved in dimeth-
ylsulfoxide (DMSO) as a stock concentration of 500 μM
and stored at -80°C. Serial dilutions were prepared in cul-
ture medium.
Cell culture
Mesenchymal stem cells (MSCs) were isolated from
canine adipose tissue biopsies and primary canine chon-
drocytes were isolated from cartilage from the femoral
head. Samples were obtained during total hip replace-
ment surgery with fully-informed owner consent and eth-Buhrmann et al. Arthritis Research & Therapy 2010, 12:R127
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ical project approval from the ethical review committee
of the Ludwig-Maximilians-University, Munich, Ger-
many. Chondrocytes and MSCs used in co-culture exper-
iments were always from the same animal. In total, the
experiments were performed three times and samples
from three different donors were used. Donor ages
ranged from five to seven years.
Briefly, for MSCs isolation, adipose tissue was cut into
small pieces and digested with collagenase 0.2% in Ham's-
F12 in a water bath at 37°C for two hours. Digested adi-
pose tissue was centrifuged at 1,000 g for five minutes
and the pellet was resuspended in cell culture medium
consisting of DMEM/Ham's-F12 1:1, 10% FCS, 1% partri-
cin solution, 1% penicillin/streptomycin solution (10 000
IU/10 000 IU), 75 μg/ml ascorbic acid, 1% essential amino
acids and 1% Glutamine, all obtained from Seromed
(Munich, Germany) in a T75 cell culture flask and incu-
bated at 37°C/5%CO2, 95% humidity. After four days,
non-adherent cells were discarded by washing with
Hank's salt solution. The medium was changed three
times per week. Adherent cells were split following for-
mation of fibroblast-like cell colonies and upon reaching
60 to 70% confluence, and were sub-cultured until the
third or fourth passage was achieved. As there are no
definitive MSC specific cellular markers, we identified
them by their ability to adhere to tissue culture plastic in
vitro, through their multilineage differentiation potential
in vitro and through a combination of expression and lack
of defined markers (CD105+, CD90+, CD45-, CD34-) [19-
22].
For chondrocyte isolation the cartilage sample was
sliced into 1 to 2 mm thick slices and incubated first with
pronase (2%/Hams-F12) (Roche Diagnostics, Mannheim,
Germany), followed by collagenase incubation (0.2%/
Ham's-F12) (Sigma) in a shaking water bath at 37°C. The
digested sample was centrifuged at 1,000 g for five min-
utes and cells plated at 1 × 106 cells per T75 flask at 37°C/
5%CO2. The first medium change was performed after 24
hours, and the following medium changes three times per
week. Chondrocytes were split at approximately 70% con-
fluency and passaged twice.
High-density culture
Three-dimensional high-density cultures at the air-liquid
interface were prepared as previously described [23].
Cells were centrifuged at 1,000 g for five minutes and
around one million cells (approximately 8 μl) from the
cell pellet were pipetted directly onto a nitrocellulose fil-
ter on a steel grid. This model allows the cells to aggre-
gate, forming a distinct pellet, which was examined after
14 days.
High-density culture pellets either consisted only of
MSCs or primary chondrocytes, or a mixture of MSCs
and primary chondrocytes (1:1) (co-culture). In all exper-
iments, cultures and co-cultures were either incubated
with cell culture medium (10% FCS) or with a chondro-
genic induction medium as described by Pittenger et al.
[24] consisting of DMEM base medium, D-(+)-glucose
0.35 g/100 ml (Sigma, Cat No. G7021), ITS+ 1 liquid
media supplement (10 μg/ml insulin, 5.5 μg/ml transfer-
rin, 5 ng/ml selenium, 0.5 mg/ml bovine albumin, 4.7 μg/
ml linoleic acid (Sigma, Cat. No. I-2521), 0.1 mM ascor-
bate-2-phosphate (Sigma, Cat. No. A-8960), 10-7 M dex-
amethasone (Sigma, Cat. No. D-8893), penicillin/
streptomycin solution (10,000 IU/10,000 IU/100 ml). 10
ng/ml hTGFβ1 (Acris Antibodies GmbH, Hiddenhausen,
Germany) were added fresh to the medium before each
medium change. Furthermore, some cultures and co-cul-
tures were then incubated with one of the following treat-
ments: curcumin only; pre-stimulated with curcumin for
four hours in suspension and then transferred to high-
density culture; 10 ng/ml IL-1β; curcumin and IL-1β; pre-
stimulated with curcumin for four hours in suspension
and then brought into high-density culture and stimu-
lated with IL-1β; or pre-stimulated with curcumin for
four hours in suspension and then brought into high-den-
sity culture and stimulated with IL-1β and curcumin.
Medium changes were made every three days.
Time and concentration dependent experiments in 
monolayer culture
To examine in more detail the interaction between cur-
cumin and IL-1β in MSCs and the pathological pathways
involved, monolayer cultures of MSCs were evaluated.
First, MSCs were cultured with various concentrations of
curcumin (0, 0.5, 1, 2 and 5 μM) for four hours, followed
by 24 hours 10 ng/ml IL-1β stimulation. Second, MSC
cultures were pre-treated for four hours with 5 μM cur-
cumin followed by one hour 10 ng/ml IL-1β stimulation.
Whole cell lysates, cytoplasmic extracts and nuclear
extracts were taken at various time points and evaluated
with Western blotting.
Electron microscopy
Transmission electron microscopy was performed as pre-
viously described [25]. High-density co-cultures were
fixed for one hour in Karnovsky-fixative fixative and
post-fixed in 1% OsO4 solution. After dehydration, pellets
were embedded in Epon, ultrathin cuts were made on a
Reichert-Ultracut E and contrasted with a mixture of 2%
uranyl acetate/lead citrate. A transmission electron
microscope (TEM 10, Zeiss, Jena, Germany) was used to
examine the co-cultures. To quantify apoptosis, the num-
ber of cells exhibiting typical morphological features of
apoptotic cell death was determined by scoring 100 cells
from 30 different microscopic fields per culture and the
number of apoptotic cells expressed as an indicator of
MSC culture degradation.Buhrmann et al. Arthritis Research & Therapy 2010, 12:R127
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Western blot analysis
For Western blotting, total cell proteins were either
extracted from the cell cultures with lysis buffer on ice for
30 minutes or nuclear extracts and cytoplasmic extracts
prepared as previously described [9]. Total protein con-
tent was measured with the bicinchoninic acid system
(Uptima, France) using bovine serum albumin as a stan-
dard. Samples were further reduced with 2-mercaptoeth-
anol and total protein concentrations adjusted. Proteins
(500 ng per lane total protein) were separated with SDS-
PAGE under reducing conditions on 5%, 7%, 10% or 12%
gels and then blotted onto nitrocellulose membranes
using a trans blot apparatus (Bio-Rad, Munich, Ger-
many). After blocking for two hours in 5% (w/v) skimmed
milk powder in phosphate buffered saline (PBS)/0.1%
Tween 20, membranes were incubated with the primary
antibodies (overnight, 4°C), followed by incubation with
the alkaline phosphatase conjugated secondary antibod-
ies for two hours at room temperature. Finally, specific
antigen-antibody complexes were detected using
nitroblue tetrazolium and 5-bromo-4-chloro-3-
indoylphosphate (p-toluidine salt; Pierce, Rockford, IL,
USA) as substrates for alkaline phosphatase. Specific
binding was quantified by densitometry using "Quantity
One" (Bio-Rad Laboratories Inc. Munich, Germany).
Results
Characterisation of canine adipose tissue derived 
mesenchymal stem cells
In order to demonstrate that the cells isolated from the
canine adipose tissue (Figure 1A) are indeed mesenchy-
mal stem cells (MSCs) we differentiated them to adipo-
cytes, osteoblasts and chondrocytes (Figure 1B, C). After
three weeks' treatment with the adipogenic induction
medium, the cells contained abundant amounts of vacu-
oles and Oil Red O staining for fat revealed that these
vacuoles contained neutral lipids (B). After three weeks
culture time with the osteogenic induction medium the
cells changed to a more polygonal appearance, formed
nodules and were stained positive with von Kossa stain
for mineral deposition (C). Alcian blue staining after 14
days in culture revealed a high content of cartilage spe-
cific proteoglycans in induced cultures (D). Additionally,
the isolated MSCs showed a strong positive signal for the
stem cell specific markers CD90+ and CD105+ (Figure 1E,
F). In contrast to this they were clearly labelled negative
for the hematopoietic stem cell markers CD45-  and
CD34- (Figure 1G, H).
Curcumin alone does not have a chondro-inductive effect 
on pure MSC high-density cultures
To study the effects of curcumin on MSCs after 14 days of
cultivation in three-dimensional high-density culture,
ultrastructural evaluations were performed (Figure 2A).
In control cultures, MSCs did not survive, but underwent
apoptosis or necrosis and mainly cell debris was observed
(a). Treatment of the cultures with the chondrogenic
induction medium stimulated chondrogenesis (b). The
formation of cartilage nodules consisting of large
rounded viable cells (containing large quantities of endo-
plasmic reticulum, mitochondria and other cellular
organelles) embedded in a fine structured, highly
organised ECM was observed. Treatment of MSCs with
curcumin alone did not stimulate chondrogenesis and, as
in control cultures, mainly cell debris was observed (c, e).
It did not make a difference whether cultures were either
Figure 1 Characterisation of MSCs. In monolayer culture the adipose derived MSCs (A) assumed a polymorphic, fibroblast-like morphology and 
could be differentiated into adipocytes (B; Oil red staining), osteoblasts (C; von Kossa) and chondrocytes (D; alcian blue). The isolated MSCs showed 
a strong positive signal for the stem cell specific markers CD90+ (E) and CD105+ (F) and were negative for the hematopoietic stem cell markers CD45- 
(G) and CD34- (H). Magnification: A: 5×; B: 40×; C: 20×; D: 20×; E-H: 40×.Buhrmann et al. Arthritis Research & Therapy 2010, 12:R127
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Figure 2 Curcumin alone does not enhance chondrogenesis in MSCs. A: 14 days high-density culture. Apoptosis or necrosis was observed in MSC 
cultures (a), MSC cultures treated with curcumin (c) or MSC cultures pre-stimulated four hours with curcumin, followed by incubation with curcumin 
(e). In contrast, chondrogenesis was observed in MSC cultures treated with the chondrogenic induction medium alone (b), in combination with cur-
cumin (d) or a hour-hour pre-stimulation with curcumin, followed by a combination of curcumin and the chondrogenic induction medium (f). Mag-
nification, 6000×; bar, 1 μm; C, chondrocytes; F, fibroblast-like cells; M, ECM; GF, chondrogenic induction medium. B: The ultrastructural findings above 
were confirmed by western blotting. Immunoblots of whole cell lysates were probed using antibodies that recognize CSPGs, collagen type II, β1-in-
tegrin, Shc, activated-ERK1/2 and Sox-9. Each experiment was performed in triplicate. Expression of the housekeeping gene β-actin was not affected. 
GF, chondrogenic induction medium.Buhrmann et al. Arthritis Research & Therapy 2010, 12:R127
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pre-treated for four hours with curcumin (c) or pre-
treated four hours with curcumin followed by treatment
with curcumin over the entire culture period (e). In con-
trast, in cultures treated with curcumin and the chondro-
genic induction medium (d, f) chondrogenesis was
observed. Chondrogenesis was similar in cultures that
were either pre-treated for four hours with curcumin (d)
or cultures that were pre-treated four hours with cur-
cumin followed by treatment with curcumin over the
entire culture period (f).
Western blotting was performed to confirm these
results (Figure 2B). Whole cell lysates were resolved by
SDS-PAGE electrophoresis and blotted onto nitrocellu-
lose. The membranes were probed with antibodies
against cartilage specific proteoglycans (CSPG), collagen
type II, β1-integrins, Shc, activated extracellular regu-
lated kinases 1 and 2 (ERK 1/2) and Sox-9.
In agreement with the ultrastructural findings, MSC
cultures treated with the specific chondrogenic induction
medium alone or in combination with curcumin pro-
duced high amounts of CSPGs, collagen type II and β1-
integrin. Here, four-hour curcumin pre-treatment fol-
lowed by treatment with the chondrogenic induction
medium was as effective in inducing the production of
CSPGs, collagen type II and β1-integrin as a four-hour
curcumin pre-treatment followed by treatment with cur-
cumin and the chondrogenic induction medium over the
entire culture period. Further, in these cultures the chon-
drogenic signalling cascade was activated with high
expression of Shc, activated ERK 1/2 and Sox-9. In con-
trast to this, cartilage specific matrix components and
members of the chondrogenic signalling cascade, were
not expressed in untreated cultures or cultures incubated
only with curcumin. Again, it did not make a difference
whether cultures were pre-treated for four hours with
curcumin or pre-treated four hours with curcumin fol-
lowed by treatment with curcumin over the entire culture
period.
Curcumin inhibits IL-1β activity in MSCs, enabling growth 
factor induced chondrogenesis
It has been reported that IL-1β inhibits chondrocyte pro-
liferation and induces apoptosis [26,27]. We therefore
evaluated the effects of curcumin on MSCs stimulated
with IL-1β and/or the chondrogenic induction medium.
Ultrastructural evaluation revealed that stimulation of
MSCs with IL-1β either alone (Figure 3A-a), in combina-
tion with the chondrogenic induction medium (b) or in
combination with four-hour curcumin pre-treatment (c)
resulted in apoptosis. However, treatment with IL-1β,
curcumin and the chondrogenic induction medium lead
to induction of chondrogenesis (d, e) with formation of
cartilage nodules containing viable, rounded cells that
were embedded in a cartilage specific matrix. In these
cultures, a four-hour curcumin pre-treatment (d) was as
effective in inhibiting IL-1β induced apoptosis as a four-
hour curcumin pre-treatment followed by treatment with
curcumin over the entire culture period (e).
Apoptosis was further quantified as described in Mate-
rials and Methods. The data shown in Figure 3B demon-
strate a significantly increased number of apoptotic cells
in cultures stimulated with IL-1β either alone, in combi-
nation with the chondrogenic induction medium or in
combination with a four-hour curcumin pre-treatment.
As shown at the ultrastructural level, the number of
apoptotic cells significantly decreased in MSC cultures
treated with IL-1β, curcumin and the chondrogenic
induction medium (Figure 3B). In these cultures the
number of apoptotic cells was similar between cultures
that were either pre-treated for four hours with curcumin
or pre-treated four hours with curcumin followed by cur-
cumin treatment over the entire culture period.
To support these ultrastructural findings, Western blot-
ting was performed by probing whole cell lysates with
antibodies against CSPGs, collagen type II, β1-integrin,
Shc, activated ERK 1/2 and Sox-9 (Figure 3C). Stimula-
tion of MSC cultures with IL-1β either alone, in combina-
tion with the chondrogenic induction medium or with a
four-hour curcumin pre-treatment did not lead to pro-
duction of CSPGs, collagen type II, β1-integrin and acti-
vation of Shc, ERK 1/2 and Sox-9. In contrast, production
of CSPGs, collagen type II and β1-integrin was upregu-
lated and Shc, activated ERK 1/2 and the chondrogenic
specific transcription factor Sox-9 was highly expressed
in MSC cultures treated with IL-1β, curcumin and the
chondrogenic induction medium. Underlining the ultra-
structural findings, it did not make a difference whether
cultures were either pre-treated for four hours with cur-
cumin or pre-treated four hours with curcumin followed
by curcumin treatment over the entire culture period.
Further, to demonstrate the influence of curcumin on
the induction of the apoptotic signalling cascade by IL-1β
in MSCs, cultures were evaluated for activated caspase-3
and the marker of inflammation and prostaglandin pro-
duction COX-2 (Figure 3D). Production of activated cas-
pase-3 and COX-2 expression was prominent in all MSC
cultures stimulated with IL-1β alone and was blocked in
all cultures treated with IL-1β and curcumin. Here, a
four-hour pre-treatment with curcumin was as effective
in inhibiting the IL-1β induced apoptotic signalling cas-
cade as a four-hour pre-treatment with curcumin fol-
lowed by curcumin treatment over the entire culture
period.
Curcumin promotes chondrogenesis in co-cultures 
stimulated with IL-1β
As demonstrated above, MSC cultures treated with a
chondro-inductive medium undergo chondrogenesisBuhrmann et al. Arthritis Research & Therapy 2010, 12:R127
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Figure 3 Curcumin inhibits IL-1β activity, enabling growth factor induced chondrogenesis in MSCs. A: Fourteen days high-density culture. 
Treatment of MSC cultures with IL-1β alone (a), IL-1β and the chondrogenic induction medium (b) or a four-hour pre-stimulation with curcumin fol-
lowed by IL-1β incubation (c) resulted in apoptosis or necrosis of the cells. In contrast, a four-hour pre-stimulation of MSCs with curcumin followed 
by incubation with IL-1β and the chondrogenic induction medium (d) or followed by incubation with IL-1β, the chondrogenic induction medium 
and curcumin (e) resulted in chondrogenesis. Magnification, 6,000×; bar, 1 μm; C, chondrocytes; F, fibroblast-like cells; M, ECM; GF, chondrogenic in-
duction medium. B: Apoptotic cells were counted as an indicator of MSC culture degradation. In cultures stimulated with IL-1β alone, with IL-1β and 
the chondrogenic induction medium, or with IL-1β and curcumin the number of apoptotic cells was increased. The number of apoptotic cells re-
mained significantly lower in MSC cultures stimulated with IL-1β, curcumin and the chondrogenic induction medium. Significant values are marked 
with (*). C-D: Immunoblots of whole cell lysates were probed using antibodies that recognize CSPGs, collagen type II, β1-integrin, Shc, activated-ERK1/
2, Sox-9, activated-caspase-3 and COX-2. Each experiment was performed in triplicate. Expression of the housekeeping gene β-actin was not affected. 
GF, chondrogenic induction medium.Buhrmann et al. Arthritis Research & Therapy 2010, 12:R127
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despite the presence of IL-1β if the apoptotic and inflam-
matory cascades induced by IL-1β are inhibited by cur-
cumin. Next we evaluated whether the same effect can be
observed in a co-culture model of MSCs and primary
chondrocytes.
Ultrastructural evaluation demonstrated cellular debris
in untreated MSC cultures (Figure 4A-a), and develop-
ment of cartilage nodules with rounded, viable cells
embedded in a highly organised, fine structured ECM in
untreated primary chondrocyte cultures (b) and in
untreated co-cultures (c). Stimulation of co-cultures with
IL-1β resulted in cellular degradation (d). Curcumin
treatment of the co-cultures, either as a four-hour pre-
treatment (e) or over the entire culture period (f) did not
impede chondrogenesis. Combinational treatment of co-
cultures with IL-1β and curcumin suppressed the adverse
effects of IL-1β on chondrogenesis (g, h). Here, inhibition
of IL-1β induced apoptosis was as effectively blocked by a
four-hour curcumin treatment (g) as by curcumin treat-
ment for the entire culture period (h).
Western blotting using antibodies against CSPGs, col-
lagen type II, β1-integrin, Shc, activated ERK 1/2 and
Sox-9 was performed to evaluate induction of chondro-
genesis in the co-cultures on a molecular level (Figure 4B,
C). Production of cartilage matrix specific markers and of
chondrogenic signalling pathway members was slight in
untreated MSC cultures and high in untreated primary
chondrocyte cultures and untreated co-cultures (Figure
4B, C). Stimulation of co-cultures with IL-1β alone inhib-
ited production and expression of CSPGs, collagen type
II, β1-integrin, Shc, activated ERK 1/2 and Sox-9. In con-
trast, co-cultures stimulated with IL-1β and curcumin
produced high levels of chondrogenic matrix specific
markers (Figure 4B) and chondrogenic signalling pathway
proteins (Figure 4C). Stimulation of chondrogenesis was
similar between cultures that were either pre-treated for
four hours with curcumin or were pre-treated four hours
with curcumin followed by curcumin treatment over the
entire culture period and comparable to untreated pri-
mary chondrocyte cultures and untreated co-cultures.
To further demonstrate the influence of curcumin on
the induction of the apoptotic signalling cascade by IL-1β
in co-cultures, cultures were evaluated for activated cas-
pase-3 and the marker of inflammation and prostaglan-
din production COX-2 (Figure 4D). Activated caspase-3
and COX-2 were highly expressed in untreated MSC cul-
tures but were not expressed in untreated primary chon-
drocyte cultures and untreated co-cultures. Treatment of
the co-cultures with IL-1β alone led to high production of
activated caspase-3 and COX-2. In contrast, in co-cul-
tures stimulated with both IL-1β and curcumin neither
activated caspase-3 nor COX-2 was detected. A four-
hour pre-treatment of curcumin or curcumin treatment
over the entire culture period both effectively inhibited
IL-1β induced activation of caspase-3 and COX-2 pro-
duction. These results confirm the ultrastructural find-
ings described above and demonstrate that curcumin
inhibits IL-1β induced apoptotic and inflammatory sig-
nalling pathways, promoting co-culture induced chon-
drogenesis.
Curcumin suppresses IL-1β-induced apoptotic and 
inflammatory responses in MSCs in a time and 
concentration dependent manner
Further experiments were carried out to evaluate the
interaction between curcumin and IL-1β in MSCs. These
experiments demonstrated that curcumin suppressed IL-
1β induced activation of apoptotic and inflammatory
pathways in a concentration (Figure 5) and time (Figure
6) dependent manner.
As shown in Figure 5A, treatment with as little as 0.5
μM of curcumin over the entire culture period was suffi-
cient to significantly suppress IL-1β induced activation of
caspase-3 and COX-2 production in MSCs. Pro-caspase-
3 production remained unaffected.
The IL-1β-activated transcription factor nuclear factor-
κB (NF-κB) plays an essential role in mediating inflam-
matory and apoptotic processes in chondrocytes and it is
known that in chondrocytes, curcumin is able to suppress
NF-κB [9,14,28]. To evaluate whether curcumin influ-
ences IL-1β-induced NF-κB in MSCs, we investigated the
NF-κB signalling pathway. As demonstrated in Figure 5B,
curcumin suppressed IL-1β-induced activation of Iκ-Bα
in MSCs. This correlated clearly with decreased NF-κB
translocation to the nucleus. Inhibition of Iκ-Bα phos-
phorylation as well as NF-κB translocation to the nucleus
was evident when curcumin was included at a concentra-
tion of 0.5 μM. Higher concentrations of curcumin com-
pletely blocked IL-1β-induced activation of Iκ-Bα and
NF-κB translocation to the nucleus (Figure 5B).
Further, pre-treatment of MSC cultures with 5 μM cur-
cumin also inhibited IL-1β-induced activation of caspase-
3 and COX-2 expression in a time dependent manner
(Figure 6A). After 60 minutes incubation time, activation
of caspase-3 and COX-2 production was completely sup-
pressed. Pre-treatment of MSC cultures with 5 μM cur-
cumin also inhibited activation of Iκ-Bα and NF-κB
translocation to the nucleus in a time dependent fashion
(Figure 6B). In contrast, in IL-1β treated control cultures,
activated caspase-3, higher expression of COX-2, acti-
vated Iκ-Bα and higher concentrations of NF-κB in the
nucleus were observed.
Discussion
The aim of this study was to evaluate whether curcumin
has the capacity to modulate inflammatory processes inBuhrmann et al. Arthritis Research & Therapy 2010, 12:R127
http://arthritis-research.com/content/12/4/R127
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Figure 4 Curcumin inhibits IL-1β activity, enabling co-culture induced chondrogenesis in MSCs. A: Fourteen days high-density culture. Un-
treated MSC cultures became apoptotic (a). In primary chondrocyte cultures (b), co-cultures (c), co-cultures treated with curcumin (e) or co-cultures 
pre-stimulated four hours with curcumin (f), prominent chondrogenesis was observed. Stimulation of the co-culture with IL-1β alone resulted in de-
generation of the cell culture (d). In contrast, a four-hour pre-stimulation of the co-culture with curcumin followed by IL-1β incubation (g) or a four-
hour pre-stimulation of the co-culture with curcumin followed by IL-1β and curcumin incubation (h) inhibited the adverse effects of IL-1β on the 
chondrogenic potential of the co-culture and prominent chondrogenesis was observed. Magnification, 6,000×; bar, 1 μm; C, chondrocytes, F, fibro-
blast-like cells; M, ECM. B-D: Immunoblots of whole cell lysates were probed with antibodies against CSPGs, collagen type II, β1-integrin, Shc, activat-
ed-ERK1/2, Sox-9, activated-caspase-3 and COX-2. In co-cultures pre-stimulated for four hours with curcumin followed either by incubation with IL-
1β alone or incubation with IL-1β and curcumin, prominent production of chondrogenic matrix and adhesion molecules (B), activation of the chon-
drogenic signalling pathway (C) and down-regulation of apoptotic and inflammatory markers (D) was observed. Each experiment was performed in 
triplicate. Expression of the housekeeping gene β-actin was not affected.Buhrmann et al. Arthritis Research & Therapy 2010, 12:R127
http://arthritis-research.com/content/12/4/R127
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Figure 5 Curcumin suppresses IL-1β-induced apoptotic and inflammatory responses in monolayers of MSCs in a concentration dependent 
manner. Monolayer cultures of MSCs were pre-stimulated for four hours with various concentrations of curcumin (0, 0.5, 1, 2 and 5 μM) followed by 
24 h incubation with IL-1β, and Western blotting was performed using whole cell lysates and nuclear extracts. A: A strong dose dependent effect on 
IL-1β induced activation of caspase-3 and COX-2 was observed. Curcumin concentrations as low as 0.5 μM suppresses IL-1β induced activation of 
caspase-3 and COX-2. Higher concentrations of curcumin completely inhibited IL-1β induced activation of caspase-3 and production of COX-2. This 
was confirmed by quantitative densitometry. The mean values and standard deviations from three independent experiments are shown. Expression 
of the housekeeping gene β-actin was not affected. B: Curcumin exerts a strong dose dependent effect on IL-1β activated Iκ-Bα in MSCs, by suppress-
ing phosphorylation of Iκ-Bα (which is already fairly robust) and NF-κB nuclear translocation at 0.5 μM curcumin. Higher concentrations of curcumin 
blocked IL-1β-induced activation of Iκ-Bα and NF-κB translocation to the nucleus completely. This was confirmed by quantitative densitometry. The 
mean values and standard deviations from three independent experiments are shown. Expression of the housekeeping gene β-actin and the DNA 
repair enzyme PARP were not affected.Buhrmann et al. Arthritis Research & Therapy 2010, 12:R127
http://arthritis-research.com/content/12/4/R127
Page 11 of 15
Figure 6 Curcumin revokes IL-1β-induced apoptotic and inflammatory responses in monolayers of MSCs in a time dependent manner. MSC 
Monolayer cultures were pre-stimulated for four hours with 5 μM curcumin followed by 1 h stimulation with IL-1β. Whole cell lysates, cytoplasmic and 
nuclear extracts were evaluated by western blotting at various time points. A: A four-hour pre-stimulation with 5 μM curcumin suppressed IL-1β in-
duced activation of caspase-3 and expression of COX-2 in a time dependent manner. This was confirmed by quantitative densitometry. The mean 
values and standard deviations from three independent experiments are shown. Expression of the housekeeping gene β-actin was not affected. B: 
Western blotting against activated Iκ-Bα and NF-κB demonstrated that in cultures pre-stimulated with 5 μM curcumin for four hours, followed by one-
hour IL-1β stimulation, neither activation of Iκ-Bα nor translocation of NF-κB to the nucleus can be demonstrated. This was confirmed by quantitative 
densitometry. The mean values and standard deviations from three independent experiments are shown. Expression of the housekeeping gene β-
actin and the DNA repair enzyme PARP were not affected.Buhrmann et al. Arthritis Research & Therapy 2010, 12:R127
http://arthritis-research.com/content/12/4/R127
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MSCs and thus support chondrogenesis in an in vitro
model of OA incorporating MSCs, primary chondrocytes
and pro-inflammatory cytokines.
Our observations lead to the following conclusions: (1)
Curcumin itself does not have any chondro-inductive
potential in MSCs, and treatment of MSCs with IL-1β
l e a d s  t o  c e l l  a p o p t o s i s .  ( 2 )  A l t h o u g h  c o - t r e a t m e n t  o f
MSCs with curcumin and IL-1β does not promote chon-
drogenesis, it clearly inhibits up-regulation of pro-inflam-
matory and apoptotic signalling cascades in MSCs; (3) If
MSCs receive a chondrogenic stimulus, curcumin medi-
ated inhibition of IL-1β-induced catabolic signalling cas-
cades enables chondrogenic differentiation. (4) This
effect is observed either by pre-treatment with curcumin
(four hours) or curcumin incubation over the entire cul-
ture period. (5) Chondrogenic stimulation can be
achieved either with a chondro-inductive medium or
through direct, close contact co-culture of MSCs with
primary chondrocytes; (6) Similar to chondrocytes, cur-
cumin in MSCs targets the Iκ-Bα cascade, inhibiting IL-
1β-induced Iκ-Bα phosphorylation and NF-κB nuclear
translocation; (7) The effects of curcumin on the IL-1β
signalling pathway in MSCs are time and concentration
dependent.
OA and RA are characterised by high levels of pro-
inflammatory cytokines in the articular joint. These are
produced by synovial lining cells, macrophages and the
chondrocytes themselves further exacerbating cartilage
degrading and degenerative processes [29,30]. Although,
as in numerous other tissues, MSC-like progenitors are
also resident in adult cartilage tissue [10], these degrading
and degenerative processes gradually lead to an imbal-
ance between cartilage catabolism and anabolism, imped-
ing MSC chondrogenesis. It has been reported that
activation of NF-κB is the key to induction of inflamma-
tion during OA and RA, and that NF-κB inhibition might
prove to be a potential concept for arthritis treatment
[31,32].
The polyphenol curcumin, derived from the rhizomes
of Curcuma longa is a promising therapeutic agent for the
treatment of OA and RA as it has pro-apoptotic proper-
ties in synovial lining cells [33,34] and has been shown to
have anti-inflammatory and anti-apoptotic effects in
chondrocytes [14,15]. In chondrocytes these effects are
mainly mediated by inhibiting IL-1β-induced activation
of NF-κB and thus suppression of caspase-3 activation, of
production of COX-2 and upregulation of MMPs [9].
In this study we demonstrate that the IL-1β-induced
catabolic signalling cascade is suppressed by curcumin in
M S C s  a s  w e l l  a s  i n  c h o n d r o c y t e s .  F u r t h e r ,  w e  c l e a r l y
demonstrate that IL-1β induced Iκ-Bα activation is sup-
pressed by curcumin, resulting in suppression of NF-κB
translocation to the nucleus and attenuated activation of
caspase-3 and COX-2 production. Taken together, our
experiments on MSCs demonstrate that time and con-
centration dependent effects of curcumin inhibit the
induction of degradative and inflammatory pathways by
IL-1β through revoking activation of caspase-3, produc-
tion of COX-2, phosphorylation of Iκ-Bα and inhibition
of nuclear translocation of NF-κB.
Interestingly, although we demonstrated that MSCs in
high-density culture cannot survive without a chondro-
genic stimulus, stimulating these untreated cultures with
IL-1β and curcumin neither activated caspase-3 nor pro-
d u c t i o n  o f  C O X - 2 .  T h i s  s u g g e s t s  t h a t  a l t h o u g h  M S C s
alone in this high-density model do not survive without a
necessary stimulus, they become necrotic rather than
apoptotic.
We did not observe a chondrogenic effect of curcumin
alone on MSCs, despite demonstrating anti-inflamma-
tory and anti-apoptotic effects of curcumin in MSCs.
However, given the necessary stimulus, chondrogenesis
was observed. This demonstrates that curcumin inter-
feres with the IL-1β induced apoptotic pathways in MSCs
thus providing a suitable microenvironment allowing
MSCs to undergo chondrogenesis even in the presence of
IL-1β, as long as MSCs simultaneously receive the correct
differentiation stimulus. This was confirmed through
high production of ECM and adhesion and signalling
molecules such as β1-Integrin. Similar observations have
been made in chondrocytes [15]. Interestingly, integrins
have already been shown in several tissues to be able to
mediate curcumin action [35,36]. As β1-integrins are
highly expressed in developing and adult cartilage, it is
possible that the mechanism of action of curcumin in
MSCs and chondrocytes might involve the β1-integrin
receptor signalling pathway.
Several studies have suggested that curcumin interacts
with the TGF-β signaling cascade, modulating the action
of TGF-β. For example in renal cells curcumin blocks
multiple sites of the TGF-β signaling [37] or Smad inhibi-
tion in human proximal tubule cells [38]. However, no
previously published in vitro studies have explored the
potential interaction between TGF-β and curcumin in
chondrocytes.
In our experiments we did not observe inhibition (or a
major difference in) the amounts of extracellular matrix
production and signaling cascades when co-cultures were
treated with the chondrogenic induction medium and
curcumin or only with curcumin, we assume that here a
possible interaction between curcumin and the TGF-β
signaling pathway does not have an inhibitory effect on
positive chondrogenic signaling. However, interaction of
curcumin and TGF-β signaling in chondrocytes is an
interesting point and will require further detailed investi-
gations.
In the present study we demonstrated that a fairly low
concentration of curcumin (0.5 μM) was sufficient toBuhrmann et al. Arthritis Research & Therapy 2010, 12:R127
http://arthritis-research.com/content/12/4/R127
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inhibit IL-1β induced activation of degradative pathways
in MSCs. It must be noted that in this study we worked
with low concentrations of curcumin, the highest concen-
tration used being 5 μM. We chose this concentration
based on previous studies in our laboratory demonstrat-
ing that canine MSCs do not tolerate curcumin concen-
trations higher than 5 μM. A recent study by Kim and co-
workers demonstrated that chick MSCs treated with 20
μM curcumin become apoptotic and do not undergo
chondrogenesis [39]. This clearly demonstrates that
MSCs can only tolerate lower concentrations of curcumin
in contrast to chondrocytes [40]. However, in vivo admin-
istered doses of curcumin in clinical trials differ greatly
from this and have ranged between 2 to 10 g per day [41-
43]. An explanation for these high concentrations is that
intestinal absorption of curcumin is fairly low, mainly due
to the fact that curcumin is practically insoluble in water,
and that it has a low bio-availability [44,45]. Despite its
low bio-availability, efficacy has been demonstrated in
several in vivo studies [46-48].
In order to develop a therapeutic strategy for OA/RA
treatment with curcumin it would be interesting to deter-
mine bioavailability of curcumin in the synovial fluid fol-
lowing various routes of administration (that is, oral,
intra articular or topical). This is especially interesting as
it may be also possible that in vivo curcumin exerts its
effects via another organ (that is, the liver), which then
leads to positive anabolic signalling in the joint. There-
fore, to integrate our in vitro data with results from other
studies, it is important to design and perform further in
vivo studies. Furthermore, our experiments were carried
out using canine derived cells and it may not be possible
to make generalised statements about the activity of cur-
cumin on MSC-like cells in other species.
Conclusions
Our results suggest that curcumin, the naturally occur-
ring NF-κB inhibitor, protects MSCs from the deleterious
effects of pro-inflammatory cytokines and thus creates a
suitable microenvironment for MSCs to undergo chon-
drogenesis and this strategy may help stimulate cartilage
regeneration  in vitro (Figure 7). We therefore propose
curcumin as a potential new therapeutic for the prophy-
lactic treatment of OA/RA and for OA/RA cases where
cartilage damage is marginal.
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Figure 7 Schematic demonstrating the inflammatory cycle that 
inhibits chondrogenic differentiation of MSCs in OA and the ef-
fect of curcumin. Trauma, inflammation or a combination of both (1) 
lead to the production and accumulation of high levels of pro-inflam-
matory cytokines (2) in the joint. These trigger the production of addi-
tional pro-inflammatory cytokines which induce genes encoding 
prostaglandin synthesizing enzymes (that is, COX-2) and matrix de-
grading enzymes (3) such as MMPs and aggrecanases. These events 
promote cartilage degradation and stimulate further joint inflamma-
tion (4) and a self-perpetuating inflammatory and catabolic cascade 
develops. As illustrated, cartilage contains chondrocytes and MSC-like 
progenitors (5). Chemical or biological agents may help create a suit-
able microenvironment in order for these progenitor cells to undergo 
chondrogenesis and regenerate new cartilage in OA. In this study we 
tested the hypothesis that phytochemical modulators of NF-κB can 
counteract this inflammatory and catabolic cascade and demonstrat-
ed that curcumin (6) has the capacity to block the action of pro-inflam-
matory cytokines in the joint thus disrupting the inflammatory cycle.Buhrmann et al. Arthritis Research & Therapy 2010, 12:R127
http://arthritis-research.com/content/12/4/R127
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